- Briefing Your roundup of Asian tech and startup news that matter
In brief: Singapore’s ASTAR inks $90m deal to create healthcare startups
- Singapore’s Agency for Science, Technology and Research (ASTAR) commercialization arm Accelerate signed a US$90 million deal with Hong Kong-based public pharmaceutical company Aptorum Group and financial firm Aeneas Capital to co-create local deep-tech startups in the healthcare and life sciences spaces, The Business Times reports.
- Aptorum and Accelerate also look to create up to 20 Singaporean deep tech ventures over the next five years.
- Additionally, Aptorum and Aeneas Capital will launch a US$200 million fund for healthcare and life science strategic investments, which may be used to invest in Hong Kong’s biotech ecosystem.
Editing by Dante Gagelonia
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.





